Novavax’s long-awaited COVID-19 vaccine authorizations offer an alternative to mRNA | Science
The small Maryland biotechnology company Novavax has finally joined the ranks of high-profile COVID-19 vaccine developers after winning emergency authorizations in recent days for its candidate. The decisions by the World Health Organization (WHO) and the European Commission make the company’s product the first protein-based vaccine green-lighted by those bodies and opens it to broad … Read more